User profiles for "author:Gerald Gartlehner"

Gerald Gartlehner

Head of Department for Evidence-based Medicine and Evaluation
Verified email at donau-uni.ac.at
Cited by 28086

Perinatal depression: a systematic review of prevalence and incidence

NI Gavin, BN Gaynes, KN Lohr… - Obstetrics & …, 2005 - journals.lww.com
OBJECTIVE: We systematically review evidence on the prevalence and incidence of
perinatal depression and compare these rates with those of depression in women at …

[HTML][HTML] Perinatal depression: Prevalence, screening accuracy, and screening outcomes: Summary

BN Gaynes, N Gavin, S Meltzer-Brody… - AHRQ evidence …, 2005 - ncbi.nlm.nih.gov
Depression is the leading cause of disease‐related disability among women. 1 In particular,
women of childbearing age are at high risk for major depression. 2‐4 Pregnancy and new …

[HTML][HTML] Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviews

C Garritty, G Gartlehner, B Nussbaumer-Streit… - Journal of clinical …, 2021 - Elsevier
Objectives To develop methods guidance to support the conduct of rapid reviews (RRs)
produced within Cochrane and beyond, in response to requests for timely evidence …

Quarantine alone or in combination with other public health measures to control COVID‐19: a rapid review

B Nussbaumer-Streit, V Mayr… - Cochrane Database …, 2020 - cochranelibrary.com
Background Coronavirus disease 2019 (COVID‐19) is a rapidly emerging disease classified
as a pandemic by the World Health Organization (WHO). To support the WHO with their …

Outcomes of routine episiotomy: a systematic review

K Hartmann, M Viswanathan, R Palmieri, G Gartlehner… - Jama, 2005 - jamanetwork.com
ContextEpisiotomy at the time of vaginal birth is common. Practice patterns vary widely, as
do professional opinions about maternal risks and benefits associated with routine use …

Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis

RA Hansen, G Gartlehner, AP Webb… - … interventions in aging, 2008 - Taylor & Francis
Pharmacologic treatments for Alzheimer's disease include the cholinesterase inhibitors
donepezil, galantamine, and rivastigmine. We reviewed their evidence by searching …

Conducting quantitative synthesis when comparing medical interventions: AHRQ and the Effective Health Care Program

R Fu, G Gartlehner, M Grant, T Shamliyan… - Journal of clinical …, 2011 - Elsevier
OBJECTIVE: This article is to establish recommendations for conducting quantitative
synthesis, or meta-analysis, using study-level data in comparative effectiveness reviews …

[HTML][HTML] The GRADE Working Group clarifies the construct of certainty of evidence

M Hultcrantz, D Rind, EA Akl, S Treweek… - Journal of clinical …, 2017 - Elsevier
Objective To clarify the grading of recommendations assessment, development and
evaluation (GRADE) definition of certainty of evidence and suggest possible approaches to …

GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence

HJ Schünemann, C Cuello, EA Akl, RA Mustafa… - Journal of clinical …, 2019 - Elsevier
Objective To provide guidance on how systematic review authors, guideline developers, and
health technology assessment practitioners should approach the use of the risk of bias in …

Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis

KE Donahue, G Gartlehner, DE Jonas… - Annals of internal …, 2008 - acpjournals.org
Background: The comparative effectiveness of rheumatoid arthritis therapies is uncertain.
Purpose: To compare the benefits and harms of disease-modifying antirheumatic drugs …